Rising VGKC Antibody Levels as a Possible Marker for ALS Progression
Author Information
Author(s): Muacevic Alexander, Adler John R, Salter Sophia, Salter Ethan, Kim Aengela Jihyoun, Liu Antonio K
Primary Institution: Adventist Health White Memorial, Los Angeles, USA
Hypothesis
Can increasing levels of VGKC-complex antibodies serve as biomarkers for disease progression in ALS patients?
Conclusion
The study suggests that rising VGKC-complex antibody levels may correlate with disease progression in ALS patients who test positive for these antibodies.
Supporting Evidence
- The patient's VGKC-complex antibody levels increased from 242 pmol/L to 279 pmol/L over six months.
- The ALS Functional Rating Scale score declined from 30 to 26 during the same period.
- VGKC antibody levels may indicate disease progression in certain ALS subtypes.
Takeaway
This study looked at one patient with ALS and found that as their VGKC antibody levels went up, their symptoms got worse, which might help doctors track how the disease is changing.
Methodology
The case report involved monitoring VGKC-complex antibody levels and ALS Functional Rating Scale scores over time in a single ALS patient.
Limitations
The study is based on a single case, limiting the generalizability of the findings.
Participant Demographics
A 53-year-old male patient with a diagnosis of ALS.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website